Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Non-small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00991796
What this trial is testing

CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Daiichi Sankyo 109
Testing effectiveness (Phase 2)UnknownNCT03379441
What this trial is testing

Pembrolizumab (MK-3475) as Maintainance in Treated Patients With Unresectable Stage III NSCLC

Who this might be right for
Non Small Cell Lung Cancer Patients
University of Turin, Italy 126
Early research (Phase 1)Study completedNCT04895579
What this trial is testing

Lung Cancer With Copanlisib and Durvalumab

Who this might be right for
Non Small Cell Lung Cancer
Zhonglin Hao 11
Not applicableStudy completedNCT05637580
What this trial is testing

Pathological Tumor and Lymph Node Responses After Neoadjuvant Immunochemotherapy in Initially-unresectable NSCLC

Who this might be right for
Non Small Cell Lung CancerImmunotherapyChemotherapy+1 more
Guangdong Provincial People's Hospital 110
Testing effectiveness (Phase 2)Study completedNCT02720614
What this trial is testing

Hypofractionated Radiation Therapy Combined With Concurrent Chemotherapy for Patients With Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
LIN QIANG 12
Large-scale testing (Phase 3)Active Not RecruitingNCT05048797
What this trial is testing

Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small Cell Lung Cancer With HER2 Mutations

Who this might be right for
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
AstraZeneca 454
Large-scale testing (Phase 3)Active Not RecruitingNCT06151574
What this trial is testing

Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment

Who this might be right for
Lung Cancer, Non-squamous, Non-small Cell
Boehringer Ingelheim 428
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06962189
What this trial is testing

The Efficacy and Safety of Sintilimab Plus Chemotherapy in Surgical Conversion for Patients With Unresectable Stage IIIB-IIIC NSCLC: A Prospective, Single-Arm, Phase II Study

Who this might be right for
Non Small Cell Lung Cancer (Stage III)
Zhejiang University 39
Not applicableUnknownNCT04364776
What this trial is testing

Radiomic Signature as Predictive Marker of Response to Chemoradiation and Durvalumab in Stage III NSCLC.

Who this might be right for
Lung CancerLung Cancer Stage III
Fondazione IRCCS Policlinico San Matteo di Pavia 100
Early research (Phase 1)Ended earlyNCT01282333
What this trial is testing

Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer

Who this might be right for
Advanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver CancerMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+11 more
National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)UnknownNCT04982549
What this trial is testing

Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC

Who this might be right for
Unresectable Stage III NSCLC
Shandong Cancer Hospital and Institute 35
Testing effectiveness (Phase 2)Looking for participantsNCT07730021
What this trial is testing

ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
Astellas Pharma Global Development, Inc. 392
Testing effectiveness (Phase 2)Study completedNCT00094835
What this trial is testing

Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerNon-Small Cell Lung Cancer
Amgen 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT05635708
What this trial is testing

Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung CancerMetastatic Non-small Cell Lung Cancer
BeiGene 400
Not applicableUnknownNCT04161352
What this trial is testing

Endostar Combined With Concurrent Radiochemotherapy for Treatment of Unresectable Stage III NSCLC

Who this might be right for
Unresectable Stage III NSCLC
Zhejiang Cancer Hospital 500
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)UnknownNCT05351320
What this trial is testing

WX-0593 Combined With Concurrent Chemoradiotherapy in Unresectable Locally Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Jinming Yu 40
Large-scale testing (Phase 3)Study completedNCT00040885
What this trial is testing

Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)

Who this might be right for
AnorexiaCachexiaFatigue+1 more
Alliance for Clinical Trials in Oncology 67
Testing effectiveness (Phase 2)Looking for participantsNCT07408635
What this trial is testing

IBI363 (PD-1/IL-2α-bias) in Combination With Chemotherapy as Neoadjuvant Therapy in Initially Unresectable Stage III Non-Small Cell Lung Cancer

Who this might be right for
Unresectable Stage III Non-small Cell Lung CancerCarcinoma, Non-Small-Cell Lung Cancer (NSCLC)
Shanghai Pulmonary Hospital, Shanghai, China 43
Early research (Phase 1)Active Not RecruitingNCT05907304
What this trial is testing

Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations

Who this might be right for
Advanced or Metastatic Solid Tumors
Erasca, Inc. 86
Next Page